Please enable JS

July 13th – GHLF FDA Arthritis Advisory Committee comments on proposed biosimilar to ENBREL (etanercept)

7/ 15

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Jul 15, 2016

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

July 13th – GHLF FDA Arthritis Advisory Committee comments on proposed biosimilar to ENBREL (etanercept)

IMG_1541
Click here to listen to Seth’s Testimony

Click Here to view on a separate screen


 

Font Resize